MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY Application WO-2020168300-A1 World Intellectual Property Organisation (WIPO) 20 Aug 2020
GENERATION OF KNOCK-OUT PRIMARY AND EXPANDED HUMAN NK CELLS USING CAS9 RIBONUCLEOPROTEINS Application WO-2019222503-A1 World Intellectual Property Organisation (WIPO) 21 Nov 2019
ANTICANCER ADJUVANT Application WO-2018012683-A1 World Intellectual Property Organisation (WIPO) 18 Jan 2018